Page 1 of Clinical Trials for Dupont Applied Biosciences [SPONSOR-COLLABORATORS], 10 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
Last Updated: June 23, 2005
Condition(s): HIV Infections
2
Completed
Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
Last Updated: September 12, 2005
Condition(s): HIV Infections
3
Completed
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
Last Updated: June 23, 2005
Condition(s): HIV Infections
4
Completed
Individually Adapted Therapy of Alcoholism
Last Updated: June 26, 2008
Condition(s): Alcoholism
5
Completed
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
Last Updated: June 23, 2005
Condition(s): HIV Infections
6
Completed
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
Last Updated: February 8, 2007
Condition(s): Thrombosis; Thromboembolism; Venous Thrombosis
7
Completed
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
Last Updated: February 8, 2007
Condition(s): Thrombosis; Thromboembolism; Venous Thrombosis
8
Completed
Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil
Last Updated: June 22, 2011
Condition(s): Heart Disease
9
Active, not recruiting
Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study
Last Updated: July 21, 2011
Condition(s): Heart Disease
10
Completed
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
Last Updated: September 12, 2005
Condition(s): HIV Infections; Antiretroviral Naive

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Dupont+Applied+Biosciences

Page 1 of Clinical Trials for Dupont Applied Biosciences [SPONSOR-COLLABORATORS], 10 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About